North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products.

StockNews.com upgraded shares of Abbott Laboratories (NYSE:ABT – Free Report) from a buy rating to a strong-buy rating in a ...

We recently compiled a list of the Jim Cramer Highlighted Buying Opportunities in 13 Stocks. In this article, we are going to ...

A product made in Columbus reached a major milestone at the end of 2024. Ensure, a nutritional drink made by Abbott ...

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

and is promoted as the next stage in child nutrition – all in an attempt to convince parents and caregivers to buy a product toddlers don’t need.” Abbott Laboratories is purposefully ...

Investment analysts at William Blair dropped their Q1 2025 earnings estimates for shares of Abbott Laboratories in a report ...

The outlook and technical action suggest Abbott Laboratories (NYSE: ABT) will lead healthcare names like Johnson & Johnson (NYSE: JNJ) higher in 2025. While each produced a solid quarter, Abbott ...

The company's Q3 profir increased 16 per cent year-on-year (Y-o-Y) to Rs 360.78 crore as compared to Rs 310.98 crore ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...